Monday, February 13, 2012
Introducing Mood 24/7, a new tool that helps you track your mood from day to day using your mobile phone. Try it today!

Schizophrenia drug meets trial goals

(Reuters) UPDATED 2009-08-27
The experimental schizophrenia drug lurasidone improved symptoms significantly better than a placebo in a late-stage clinical trial. A six-week study of 478 patients found that the drug helped users improve their scores in the Positive and Negative Syndrome Scale, as well as the Clinical Global Impressions Severity scale, the drugmaker said. Weight gain was also less on lurasidone than in other antipsychotic drugs. Drugmaker Dainippon says it will likely seek FDA approval for the medication in early 2010.  Read full story >
See all Schizophrenia News